Sichuan, China

Ling Xiao

This inventor holds 1 USPTO granted patent. Top assignee: Chengdu Huitai Biomedicine Co., Ltd.. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ling Xiao. Retrieved from https://idiyas.com/inventor/ling-xiao-js70bh0f

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ling Xiao - Innovator in Biomedicine

Introduction

Ling Xiao is a prominent inventor based in Sichuan, China. He has made significant contributions to the field of biomedicine, particularly in the development of innovative therapeutic solutions. His work focuses on polypeptides and their applications in treating various diseases.

Latest Patents

Ling Xiao holds a patent for a polypeptide, polypeptide fragment, and derivative thereof, along with their applications. This invention is crucial for the preparation of drugs aimed at preventing and treating fibrosis diseases. The patent showcases his commitment to advancing medical science and improving patient outcomes.

Career Highlights

Ling Xiao is associated with Chengdu Huitai Biomedicine Co., Ltd., where he continues to push the boundaries of biomedicine. His innovative approach and dedication to research have positioned him as a key figure in his field. He has successfully developed a patent that reflects his expertise and vision.

Collaborations

Ling Xiao collaborates with talented individuals in his field, including Xiaomei Li and De Wei. These partnerships enhance the research and development efforts at Chengdu Huitai Biomedicine Co., Ltd., fostering an environment of innovation and creativity.

Conclusion

Ling Xiao's contributions to biomedicine through his patent and collaborative efforts highlight his role as an influential inventor. His work not only advances scientific knowledge but also has the potential to improve healthcare solutions for patients suffering from fibrosis diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…